OBJECTIVE: Prevalence rates of visual impairment and retinopathy were compared in 1992 people with normal glucose tolerance, impaired glucose tolerance (IGT), or newly diagnosed non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS: Glucose tolerance status was based on an oral glucose tolerance test after exclusion of those with a history of diabetes and/or diabetes medication use in an upper middle-class community of older white adults in southern California between 1984 and 1987. RESULTS: Although many sex-specific comparisons were made between glucose tolerance groups, only a few emerged as statistically significant. Among those, women with IGT had significantly higher age-adjusted rates of visual impairment (10.8%) than women with normal glucose tolerance (4.4%). Among men, those with IGT had significantly higher age-adjusted rates of visual impairment (7.9%) than men with newly diagnosed NIDDM (4.0%). CONCLUSIONS: Low frequencies of retinopathy were found in all three glucose tolerance groups.
OBJECTIVE: Prevalence rates of visual impairment and retinopathy were compared in 1992 people with normal glucose tolerance, impaired glucose tolerance (IGT), or newly diagnosed non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS: Glucose tolerance status was based on an oral glucose tolerance test after exclusion of those with a history of diabetes and/or diabetes medication use in an upper middle-class community of older white adults in southern California between 1984 and 1987. RESULTS: Although many sex-specific comparisons were made between glucose tolerance groups, only a few emerged as statistically significant. Among those, women with IGT had significantly higher age-adjusted rates of visual impairment (10.8%) than women with normal glucose tolerance (4.4%). Among men, those with IGT had significantly higher age-adjusted rates of visual impairment (7.9%) than men with newly diagnosed NIDDM (4.0%). CONCLUSIONS: Low frequencies of retinopathy were found in all three glucose tolerance groups.
Authors: Sannapaneni Krishnaiah; Taraprasad Das; Praveen K Nirmalan; Bindiganavale R Shamanna; Rishita Nutheti; Gullapalli N Rao; Ravi Thomas Journal: Clin Ophthalmol Date: 2007-12
Authors: Weiwei Dai; Sadie K Dierschke; Allyson L Toro; Michael D Dennis Journal: Biochim Biophys Acta Mol Basis Dis Date: 2018-09-11 Impact factor: 5.187
Authors: Akira Mima; Weier Qi; Junko Hiraoka-Yamomoto; Kyoungmin Park; Motonobu Matsumoto; Munehiro Kitada; Qian Li; Koji Mizutani; Edward Yu; Takeshi Shimada; Jongsoon Lee; Steven E Shoelson; Christian Jobin; Christian Rask-Madsen; George L King Journal: Invest Ophthalmol Vis Sci Date: 2012-12-19 Impact factor: 4.799
Authors: Ralph A Defronzo; Maryann Banerji; George A Bray; Thomas A Buchanan; Stephen Clement; Robert R Henry; Abbas E Kitabchi; Sunder Mudaliar; Nicolas Musi; Robert Ratner; Peter D Reaven; Dawn Schwenke; Frankie B Stentz; Devjit Tripathy Journal: BMC Endocr Disord Date: 2009-07-29 Impact factor: 2.763